A German Pilot Study Using AI-Assisted Interpretation of ANA Artificial intelligence is rapidly transforming medical diagnostics—from radiology to immunology. Now, a new German pilot study reveals how AI-assisted interpretation of ANA tests could lead to faster, more consistent, and more reliable diagnosis of autoimmune diseases. With this study, the University Medical Center Regensburg and Asklepios […]

The Dresden Symposium on Autoantibodies reaffirmed its role as a landmark event, bringing together world-renowned experts to discuss the latest advances in autoimmunity. The symposium provided an invaluable opportunity to explore new perspectives on autoimmune diseases, emerging biomarkers, and technological innovations that are shaping the future of diagnostics and patient care. Medipan & GA Generic […]

Anti-neutrophil cytoplasmic antibodies (ANCA) Anti-neutrophil cytoplasmic antibodies (ANCA) are key biomarkers in the diagnosis of ANCA-associated vasculitis (AAV), a group of rare but potentially life-threatening autoimmune diseases. They can also have clinical and diagnostic value in certain non-AAV conditions. Early and accurate detection of ANCA is critical for initiating treatment promptly and improving long-term outcomes. […]

November 17 – 20, 2025 | Messe Düsseldorf | Düsseldorf, Germany Medipan & GA Generic Assays at MEDICA 2025 This year, Medipan & GA Generic Assays will be participating in Hall 3 – Diagnostics Booth #3G60, where we will proudly showcase our latest products, technologies, and solutions. Visitors to our booth will have the opportunity […]

09 – 12, September 2025 | Dresden Fair | Dresden, Germany Medipan & GA at DSA 2025 – Leading Autoantibody Diagnostics Introduction to DSA 2025 We are pleased to announce that Medipan & GA Generic Assays will once again take part in the 17th Dresden Symposium on Autoantibodies (DSA) 2025. The symposium is one of […]

We are pleased to share the results of a newly published peer-reviewed study in Scientific Reports that demonstrates the diagnostic performance of the CytoBead® ANA 2 assay1. In clinical diagnostics, the detection of antinuclear antibodies (ANA) is crucial in identifying systemic autoimmune rheumatic diseases (SARDs). Traditional methods rely on a two-step algorithm: ANA screening by […]

Type 1 diabetes management has long relied on insulin injections, carbohydrate counting, and vigilant blood sugar monitoring. But how will the landscape in the near future look like? According to prominent German pediatric endocrinologist Felix Reschke (Kinder- und Jugendkrankenhaus in Hannover), the next five years could redefine treatment strategies entirely – he said in an […]

February 10 – 13, 2025 | Dubai World Trade Centre | Dubai, UAE Medipan at the WHX Labs Dubai 2026 formerly Medlab Middle East Medipan is proud to announce our participation in WHX Labs Dubai 2026 (formerly Medlab Middle East), one of the leading global exhibitions for laboratory diagnostics, healthcare technologies, and life sciences innovations. […]

In honor of those affected by scleroderma, June is recognized as Scleroderma Awareness Month, culminating in World Scleroderma Day on June 29. This day was chosen to commemorate the life of Swiss painter Paul Klee, who passed away from systemic sclerosis on June 29, 19401. Scleroderma, also known as systemic sclerosis, is a rare autoimmune […]

From September 9 to 12, 2025, the 17th Dresden Symposium on Autoantibodies will take place in Dresden, Germany. This year’s theme, “The Autoantibody Spectrum: Bridging Health, Diagnostics, and Disease,” brings together global experts for a deep dive into the evolving science of autoimmune diagnostics. The event also honors the legacy of Prof. Eng M. Tan, […]